General Manager Work Rules (Revised April 2025)
Rules of work for board secretaries (revised in April 2025)
Lingkang Pharmaceutical Group Co., Ltd.\'s evaluation report on accounting firms
Report of the Audit Committee of the Board of Directors of Lingkang Pharmaceutical Group Co., Ltd. on the performance evaluation of the accounting firm
Report on the performance of the Audit Committee of the Board of Directors of the Company in 2024
2024 Internal Control Evaluation Report
Announcement on the Company and its wholly-owned subsidiaries applying to banks for a comprehensive credit line for 2025 and providing corresponding guarantees
Notice on convening the 2024 Annual General Meeting of Shareholders
Announcement on not revising the conversion price of “Lingkang Bonds” downward
Announcement on the subsidiary vecuronium bromide for injection passing the generic drug consistency evaluation
Announcement on the results of the optional resale of “Lingkang Bonds Transfer”
An indicative announcement on “Lingkang Bonds Transfer” expected to meet the conversion price correction conditions
The 9th indicative announcement on the option to resell “Lingkang Bonds Transfer”
Eighth indicative announcement on the optional resale of “Lingkang Bonds Transfer”
Seventh indicative announcement on the option to resell “Lingkang Bonds”
Convertible debt-to-equity conversion results and share change announcement
The sixth indicative announcement on the option to resell “Lingkang Bonds Transfer”
Fifth indicative announcement on the optional resale of “Lingkang Bonds Transfer”
Fourth indicative announcement on the optional resale of “Lingkang Bonds Transfer”
Third indicative announcement on the optional resale of “Lingkang Bonds Transfer”